Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3798
Source ID: NCT05779644
Associated Drug: Liraglutide
Title: Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Metformin|Obesity, Abdominal|Diabetes Mellitus, Type 2|Abdominal Fat|Non-Alcoholic Fatty Liver Disease|Metabolism Disorder, Glucose|Metabolism Disorder, Lipid
Interventions: DRUG: Liraglutide|DRUG: Semaglutide|DRUG: Metformin
Outcome Measures: Primary: Blood glucose, Glucose metabolism index, The twelfth week of treatment|Blood insulin, Glucose metabolism index, The twelfth week of treatment|Total cholesterol, Lipid metabolism index, The twelfth week of treatment|Triglyceride, Lipid metabolism index, The twelfth week of treatment|Lipoprotein, Lipid metabolism index, The twelfth week of treatment|Weight, Measure fasting weight, The twelfth week of treatment|Abdominal fat distribution, Use Magnetic resonance imaging-proton density fat fraction to measure fat accumulation in the liver, pancreas and abdomen., The twelfth week of treatment |
Sponsor/Collaborators: Sponsor: RenJi Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 300
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2023-02-23
Completion Date: 2025-02-23
Results First Posted:
Last Update Posted: 2023-05-16
Locations: Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200127, China
URL: https://clinicaltrials.gov/show/NCT05779644